Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo Q2W	166
Overall Study	STARTED	Placebo QM	161
Overall Study	STARTED	Evolocumab Q2W	327
Overall Study	STARTED	Evolocumab QM	332
Overall Study	Received Study Drug	Placebo Q2W	164
Overall Study	Received Study Drug	Placebo QM	160
Overall Study	Received Study Drug	Evolocumab Q2W	325
Overall Study	Received Study Drug	Evolocumab QM	332
Overall Study	COMPLETED	Placebo Q2W	159
Overall Study	COMPLETED	Placebo QM	160
Overall Study	COMPLETED	Evolocumab Q2W	321
Overall Study	COMPLETED	Evolocumab QM	328
Overall Study	NOT COMPLETED	Placebo Q2W	7
Overall Study	NOT COMPLETED	Placebo QM	1
Overall Study	NOT COMPLETED	Evolocumab Q2W	6
Overall Study	NOT COMPLETED	Evolocumab QM	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02662569/flow